Literature DB >> 6885337

Genetic and epigenetic control of the pyruvate kinase isozymes in mammals.

J Marie, M J Levin, M P Simon, A Kahn.   

Abstract

In man, patients with hereditary red cell pyruvate kinase (PK) deficiency have their enzyme concomitantly affected in both red cells and liver (PK-L), such that red cell L' and liver L PK subunits appear to be encoded by the same structural gene. Very recently, a mutant M1 PK has been described in muscle from a special mouse strain in which the M2 PK was concomitantly modified. Thus, it has been suggested that the M1 and M2 PK subunits are also encoded by the same structural gene, a gene distinct from that encoding L' and L. In this paper, we show that synthesis of each of the four PK subunits is specified by a different specific mRNA. Two structural genes, but at least four different mRNAs seem therefore to control synthesis of the PK isozymes. Genetic and epigenetic mechanisms responsible for generation of this diversity at the RNA level are discussed. In addition to these mechanisms of PK diversity, some PK subunits can be modified by post-translational events. In red cells, for instance, cell aging is associated with a progressive, partial proteolysis of the C-terminal extremities of L' subunits, ultimately resulting in cleavage of the phosphorylatable site.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6885337

Source DB:  PubMed          Journal:  Isozymes Curr Top Biol Med Res        ISSN: 0160-3787


  8 in total

1.  Pyruvate kinase M2 promotes de novo serine synthesis to sustain mTORC1 activity and cell proliferation.

Authors:  Jiangbin Ye; Anthony Mancuso; Xuemei Tong; Patrick S Ward; Jing Fan; Joshua D Rabinowitz; Craig B Thompson
Journal:  Proc Natl Acad Sci U S A       Date:  2012-04-16       Impact factor: 11.205

2.  In vivo regulation of glycolytic and gluconeogenic enzyme gene expression in newborn rat liver.

Authors:  S Lyonnet; C Coupé; J Girard; A Kahn; A Munnich
Journal:  J Clin Invest       Date:  1988-06       Impact factor: 14.808

3.  Regulation of glycolytic enzyme RNA transcriptional rates by oxygen availability in skeletal muscle cells.

Authors:  K A Webster
Journal:  Mol Cell Biochem       Date:  1987-09       Impact factor: 3.396

4.  Pyruvate Kinase M2 Knockdown Suppresses Migration, Invasion, and Epithelial-Mesenchymal Transition of Gastric Carcinoma via Hypoxia-Inducible Factor Alpha/B-Cell Lymphoma 6 Pathway.

Authors:  Ning Li; Dandan Meng; Yue Xu; Ling Gao; Fengqian Shen; Xiaojing Tie; Yan Zhang; Zhenying Yi; Wenjie Shen; Zonglan Liu; Zhiqiao Xu
Journal:  Biomed Res Int       Date:  2020-12-09       Impact factor: 3.411

5.  Erythrocyte pyruvate kinase deficiency mutation identified in multiple breeds of domestic cats.

Authors:  Robert A Grahn; Jennifer C Grahn; Maria Ct Penedo; Chris R Helps; Leslie A Lyons
Journal:  BMC Vet Res       Date:  2012-10-30       Impact factor: 2.741

6.  PKM2 promotes tumor angiogenesis by regulating HIF-1α through NF-κB activation.

Authors:  Ninel Azoitei; Alexander Becher; Konrad Steinestel; Arefeh Rouhi; Kristina Diepold; Felicitas Genze; Thomas Simmet; Thomas Seufferlein
Journal:  Mol Cancer       Date:  2016-01-06       Impact factor: 27.401

7.  High expression of PKM2 synergizes with PD-L1 in tumor cells and immune cells to predict worse survival in human lung adenocarcinoma.

Authors:  Long Long; Mengxi Chen; Yu Yuan; Alex Lau Ming; Wei Guo; Kaisong Wu; Honglei Chen
Journal:  J Cancer       Date:  2020-05-18       Impact factor: 4.207

8.  Cysteine catabolism and the serine biosynthesis pathway support pyruvate production during pyruvate kinase knockdown in pancreatic cancer cells.

Authors:  Lei Yu; Shao Thing Teoh; Elliot Ensink; Martin P Ogrodzinski; Che Yang; Ana I Vazquez; Sophia Y Lunt
Journal:  Cancer Metab       Date:  2019-12-30
  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.